I analyse an argument according to which medical artificial intelligence (AI) represents a threat to patient autonomy-recently put forward by Rosalind McDougall in the The argument takes the case of IBM Watson for Oncology to argue that such technol...
In contrast to Di Nucci's characterisation, my argument is not a technoapocalyptic one. The view I put forward is that systems like IBM's Watson for Oncology create both risks and opportunities from the perspective of shared decision-making. In this ...
Biochimica et biophysica acta. Reviews on cancer
Apr 26, 2019
The strategy of using existing drugs originally developed for one disease to treat other indications has found success across medical fields. Such drug repurposing promises faster access of drugs to patients while reducing costs in the long and diffi...
BACKGROUND: Watson for oncology (WFO) is a cognitive computing system providing decision support. We evaluated the concordance rates between the treatment options determined by WFO and those determined by a multidisciplinary team (MDT).
Artificial intelligence (AI) is increasingly being developed for use in medicine, including for diagnosis and in treatment decision making. The use of AI in medical treatment raises many ethical issues that are yet to be explored in depth by bioethic...
BACKGROUND: Rapid advances in science challenge the timely adoption of evidence-based care in community settings. To bridge the gap between what is possible and what is practiced, we researched approaches to developing an artificial intelligence (AI)...
The two main branches associated with Artificial Intelligence (AI) in medicine are virtual and physical. The virtual component includes machine learning (ML) and algorithms, whereas physical AI includes medical devices and robots for delivering care....
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.